Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT03304925
Other study ID # ZA17-002
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date October 25, 2017
Est. completion date August 2022

Study information

Verified date August 2020
Source Zeltiq Aesthetics
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Evaluate the safety and efficacy of non-invasive subcutaneous fat layer reduction in the flanks.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 320
Est. completion date August 2022
Est. primary completion date August 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 22 Years to 65 Years
Eligibility Inclusion Criteria

- Male or female subjects > 22 years of age and < 65 years of age.

- Subject has clearly visible fat on the flanks, which in the investigator's opinion, may benefit from the treatment.

- No weight change exceeding 5% of body weight in the preceding month.

- Subject with body mass index (BMI) up to 30. BMI is defined as weight in pounds multiplied by 703 divided by the square of the height in inches.

- Subject agrees to maintain his/her weight (i.e., within 5%) by not making any major changes in their diet or exercise routine during the course of the study.

- Subject has read and signed the study written informed consent form.

Exclusion Criteria

- Subject has had a surgical procedure(s) in the area of intended treatment.

- Subject has had an invasive fat reduction procedure (e.g., liposuction, mesotherapy) in the area of intended treatment.

- Subject has had a non-invasive fat reduction and/or body contouring procedure in the area of intended treatment within the past 12 months.

- Subject needs to administer, or has a known history of subcutaneous injections into the area of intended treatment (e.g., heparin, insulin) within the past month.

- Subject has a known history of cryoglobulinemia, cold urticaria, or paroxysmal cold hemoglobinuria.

- Subject has a known history of Raynaud's disease, or any known condition with a response to cold exposure that limits blood flow to the skin.

- Subject has a history of bleeding disorder or is taking any medication that in the investigator's opinion may increase the subject's risk of bruising.

- Subject is taking or has taken diet pills or supplements within the past month.

- Subject has any dermatological conditions, such as moderate to excessive skin laxity, or scars in the location of the treatment sites that may interfere with the treatment or evaluation (stretch marks is not an exclusion).

- Subject has an active implanted device such as a pacemaker, defibrillator, or drug delivery system

- Subject is pregnant or intending to become pregnant during the study period (in the next 8 months).

- Subject is lactating or has been lactating in the past 6 months.

- Subject has a history of hernia in the areas to be treated.

- Subject is unable or unwilling to comply with the study requirements.

- Subject is currently enrolled in a clinical study of any other unapproved investigational drug or device.

- Any other condition or laboratory value that would, in the professional opinion of the investigator, potentially affect the subject's response or the integrity of the data or would pose an unacceptable risk to the subject.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
The ZELTIQ System
The CoolSculpting machine will be used to perform the treatments.

Locations

Country Name City State
United States SkinCare Physicians of Chestnut Hill Chestnut Hill Massachusetts
United States EpiCenter Skincare and Laser Center Dallas Texas
United States Zel Skin & Laser Specialist Edina Minnesota
United States Brian S. Biesman, MD Nashville Tennessee
United States Laser & Skin Surgery Center of New York New York New York
United States Innovation Research Center Pleasanton California
United States Laser & Skin Surgery Center of Northern California Sacramento California

Sponsors (1)

Lead Sponsor Collaborator
Zeltiq Aesthetics

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Safety endpoint in relation to adverse events Measurement of device- or procedure-related adverse events. It is expected there will be zero UADEs Final post treatment visit
Primary Effectiveness endpoint gauged by reduction in fat layer thickness Reduction in fat layer thickness as measured by ultrasound at the final post-treatment visit. Final post-treatment visit
Secondary Subject survey Subject survey as assessed by questionnaire administered at the final post-treatment visit. Final post-treatment visit
Secondary Photo review Correct identification of pre-treatment vs. final post-treatment visit images by two out of three blinded independent reviewers. Final post-treatment visit
See also
  Status Clinical Trial Phase
Completed NCT01686841 - A Pilot Clinical Trial Investigating the Effect of Cutaneous Cooling on Sebum Production N/A
Completed NCT04340388 - Contribution of Dolutegravir to Obesity and Cardiovascular Disease Phase 4
Completed NCT02554760 - Bilateral; Flank Study With Crown Cooling Insert N/A
Completed NCT04142450 - CoolSculpting® the Upper Arms and Inner Thighs in Participants of Chinese Descent (XinCOOL) N/A
Completed NCT02941146 - DualSculpting the Abdomen Using CoolSculpting N/A
Completed NCT01859091 - Pilot Study on the Submental Area N/A
Completed NCT01763775 - Clinical Trial of Transtek Body Fat Analyzer (GBF-1251-B & Other 3 Models) N/A
Completed NCT05558488 - The Effect of a Meatless,Keto Restrictive Diet on Body Composition,Strength Capacity,Oxidative Stress,Immune Response N/A
Completed NCT03738891 - CoolSculpting and EMS for the Abdomen N/A
Withdrawn NCT04199806 - Retrospective Study of Patient Surveys N/A
Completed NCT01728857 - Tissue Optimization on Cryolipolysis Procedures for Fat Layer Reduction N/A
Completed NCT01296048 - Clinical Test for Transtek Glass Body Analyzer N/A
Completed NCT02324816 - Fat Layer Reduction in the Lateral Thighs Using CoolSculpting N/A
Recruiting NCT04876118 - Effects on Cellulite Appearance N/A
Completed NCT02298322 - Subcutaneous Fat Reduction in the Submental Area N/A
Completed NCT01600638 - Non-Invasive Reduction of Fat in the Flanks of Patients With Sharp Body Curvature N/A
Completed NCT03510598 - Submental Study (Sequential Treatment Approach) Phase 4
Completed NCT01814007 - Multiple CoolSculpting Treatment Study N/A
Completed NCT01579487 - Extended Follow-Up Study for Subjects Who Participated in 2010 Study N/A
Enrolling by invitation NCT04506307 - CoolSculpting System N/A